Old Web
English
Sign In
Acemap
>
Paper
>
myeloma therapy The syndecan-1 heparan sulfate proteoglycan is a viable target for
myeloma therapy The syndecan-1 heparan sulfate proteoglycan is a viable target for
2013
Larry J. Suva
Joshua Epstein
Shmuel Yaccoby
Bart Barlogie
Ram Sasisekharan
Annamaria Naggi
Giangiacomo Torri
Benito Casu
Yang Yang
Veronica MacLeod
Yuemeng Dai
Zachary Shriver
Keywords:
Perlecan
Cell biology
Syndecan 1
Heparan Sulfate Proteoglycan
Chemistry
Correction
Cite
Save
Machine Reading By IdeaReader
56
References
0
Citations
NaN
KQI
[]